“The CellAdam Group for Cancer Research, located in Philisborosjeno Hungary was established in 1980 by Adam Kovacs.
After investing more than 30 years researching cancer treatments and prevention, Mr. Kovacs, a cancer scientist specializing in molecular biology founded the Institute.
The CellAdam trademark was originally designated to identify a 16 component pharmacological agent but has since evolved into a complete medical system consisting of three key elements: Testing, Prevention and Therapy
While the CellAdam agent is an efficient means of early stage cancer prevention, it also inhibits the malignant process, having an analgesic effect on an advanced tumor.
